Authors: SZCZEKLIK A DWORSKI R MASTALERZ L PROKOP A SHELLER JR NIZANKOWSKA E CMIEL A OATES JA

Citation: A. Szczeklik et al., SALMETEROL PREVENTS ASPIRIN-INDUCED ATTACKS OF ASTHMA AND INTERFERES WITH EICOSANOID METABOLISM, American journal of respiratory and critical care medicine, 158(4), 1998, pp. 1168-1172

Authors: DAHLEN B NIZANKOWSKA E SZCZEKLIK A ZETTERSTROM O BOCHENEK G KUMLIN M MASTALERZ L PINIS G SWANSON LJ BOODHOO TI WRIGHT S DUBE LM DAHLEN SE

Citation: B. Dahlen et al., BENEFITS FROM ADDING THE 5-LIPOXYGENASE INHIBITOR ZILEUTON TO CONVENTIONAL THERAPY IN ASPIRIN-INTOLERANT ASTHMATICS, American journal of respiratory and critical care medicine, 157(4), 1998, pp. 1187-1194

Authors: MILEWSKI M MASTALERZ L NIZANKOWSKA E SZCZEKLIK A

Citation: M. Milewski et al., NASAL PROVOCATION TEST WITH LYSINE-ASPIRIN FOR DIAGNOSIS OF ASPIRIN-SENSITIVE ASTHMA, Journal of allergy and clinical immunology, 101(5), 1998, pp. 581-586

Authors: MASTALERZ L MILEWSKI M DUPLAGA M NIZANKOWSKA E SZCZEKLIK A

Citation: L. Mastalerz et al., INTRANASAL FLUTICASONE PROPIONATE FOR CHRONIC EOSINOPHILIC RHINITIS IN PATIENTS WITH ASPIRIN-INDUCED ASTHMA, Allergy, 52(9), 1997, pp. 895-900

Authors: SZCZEKLIK A MASTALERZ L NIZANKOWSKA E CMIEL A

Citation: A. Szczeklik et al., PROTECTIVE AND BRONCHODILATOR EFFECTS OF PROSTAGLANDIN-E AND SALBUTAMOL IN ASPIRIN-INDUCED ASTHMA, American journal of respiratory and critical care medicine, 153(2), 1996, pp. 567-571